Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000526:Alprenolol / Q000494:pharmacology; D000787:Angina Pectoris / Q000188:drug therapy / Q000517:prevention & control; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D006980:Hyperthyroidism / Q000188:drug therapy; D008660:Metabolism / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy; D010275:Parasympathetic Nervous System / Q000503:physiopathology; D011433:Propranolol / Q000627:therapeutic use; D011941:Receptors, Adrenergic / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013237:Stereoisomerism
D000319:Adrenergic beta-Antagonists; D011941:Receptors, Adrenergic; D000526:Alprenolol; D011433:Propranolol